OSE Immunotherapeutics SA (OSE.PA) Stock Price

€6.27 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    3

  • Fundamental

    8

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on OSE Immunotherapeutics SA, AI stock picks, stock alerts and much more.

Sign up

OSE.PA AI Stock Analysis

AI stock analysis for OSE.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like OSE Immunotherapeutics SA (OSE.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

OSE Immunotherapeutics SA (OSE.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of OSE Immunotherapeutics SA (OSE.PA), currently trading at €6.27, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About OSE.PA

LSE

  • OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases.

  • Symbol

    OSE.PA

  • Market

    EURONEXT

  • Industry

    Biotechnology

  • Market Cap

    137.1M

Similar Stocks

VLA.PA Valneva SE
VLA.PA		 €3.39
0.4%
3
TUB.BR Financière de Tubize SA
TUB.BR		 €141.6
1%
5
UCB.BR UCB SA
UCB.BR		 €178.8
0.5%
6
IPH.PA Innate Pharma S.A.
IPH.PA		 €1.88
0.2%
2
PHARM.AS Pharming Group
PHARM.AS		 €0.839
4.6%
3

News

OSE Immunotherapeutics and GERCOR Announce Positive Topline Phase 2 Result for Clinical Trial TEDOPaM Evaluating OSE2101 (Tedopi®) in Advanced Pancreatic Cancer

OSE Immunotherapeutics and GERCOR Announce Positive Topline Phase 2 Result for Clinical Trial TEDOPaM Evaluating OSE2101 (Tedopi®) in Advanced Pancreatic Cancer
March 11, 2025. GlobeNewswire
OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy

OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy
January 29, 2025. GlobeNewswire
OSE Immunotherapeutics Presents Three Abstracts for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ECCO

OSE Immunotherapeutics Presents Three Abstracts for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ECCO
January 27, 2025. GlobeNewswire
OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO

OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO
December 18, 2024. GlobeNewswire

OSE.PA Alternative Data

Web Traffic

OSE Immunotherapeutics SA receives an estimated 3934 monthly visitors to ose-immuno.com.

  • Web Traffic

    3934

  • Change from Previous Month

    25%

  • 3 Month Change

    42.6%

  • YoY Change

    42.6%

News Mentions

OSE Immunotherapeutics SA was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

OSE Immunotherapeutics SA has 2,150 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.4% over the last month.

  • Twitter Followers

    2150

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    1.6%

LinkedIn Followers

17,714 are following OSE Immunotherapeutics SA on LinkedIn, up by 1.3% over the last month.

  • LinkedIn Followers

    17714

  • Daily Change

    0%

  • 1 Month Change

    1.3%

  • 3 Month Change

    5%

Job Postings

OSE Immunotherapeutics SA currenly has an estimated 1 open job postings.

  • Job Postings

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Reddit Mentions

OSE Immunotherapeutics SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

LinkedIn Employees

According to LinkedIn, OSE Immunotherapeutics SA has 83 employees, up by 1.2% over the last month.

  • LinkedIn Employees

    83

  • Daily Change

    0%

  • 1 Month Change

    1.2%

  • 3 Month Change

    9.2%

Business Outlook

According to employee reviews, the business outlook among employees at OSE Immunotherapeutics SA is 58 out of 100 (neutral).

  • Business Outlook

    58

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

OSE.PA Financials

OSE.PA Key Metrics

  • Total Revenue

    €69M

  • Net Income

    €57.2M

  • Earnings per Share

    €2.63

  • Free cash flow

    €66.6M

  • EBITDA

    €60.6M

  • EBITDA Ratio

    0.878212

  • Total Assets

    €140.9M

OSE.PA 2-year Revenue & Income
OSE.PA 2-year Free Cash Flow

OSE.PA Technicals

OSE.PA SMA
OSE.PA RSI

FAQ

What's the current price of OSE Immunotherapeutics SA (OSE.PA) Stock?
The price of an OSE Immunotherapeutics SA (OSE.PA) share is €6.27.

What's the market cap of OSE Immunotherapeutics SA?
The current market cap of OSE Immunotherapeutics SA is 137.1M.

Should I buy or sell OSE.PA?
OSE Immunotherapeutics SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, OSE Immunotherapeutics SA is better viewed as a hold or accumulate position while waiting for further developments.

Is OSE Immunotherapeutics SA a good investment?
The current analysis of OSE Immunotherapeutics SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in OSE Immunotherapeutics SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy OSE Immunotherapeutics SA (OSE.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for OSE Immunotherapeutics SA stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to OSE Immunotherapeutics SA (OSE.PA) that investors often compare it to?
OSE Immunotherapeutics SA (OSE.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, UCB SA, Innate Pharma S.A. and Pharming Group.

What is the forecast for OSE Immunotherapeutics SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast OSE Immunotherapeutics SA's stock price to be around €6.28 in 2026. Starting from the current price of €6.27, this represents a 0.1% change in price, indicating a neutral outlook for the stock.

How to buy OSE Immunotherapeutics SA (OSE.PA) Stock?
OSE Immunotherapeutics SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy OSE Immunotherapeutics SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.